
STAAR Surgical (STAA) Stock Forecast & Price Target
STAAR Surgical (STAA) Analyst Ratings
Bulls say
Staar Surgical is expected to experience a rebound in sales, specifically in China, due to a recovery in the refractive surgery market, growth in the phakic IOL segment, and the company's dominant market share in this sector. However, there are risks such as macroeconomic factors and competition from local Chinese manufacturers that could affect the company's future growth. Despite uncertainties, the overall outlook is positive as the company is showing progress in China and has a strong product portfolio.
Bears say
Staar Surgical is facing challenges in its key foreign market and leadership changes, which may affect its stable revenue. Regulatory approval and competition are potential risks, and the stock may be undervalued, but market sentiment and liquidity and operational issues could lead to compression. A slow-growth outlook and structural challenges may limit potential for valuation improvement.
This aggregate rating is based on analysts' research of STAAR Surgical and is not a guaranteed prediction by Public.com or investment advice.
STAAR Surgical (STAA) Analyst Forecast & Price Prediction
Start investing in STAAR Surgical (STAA)
Order type
Buy in
Order amount
Est. shares
0 shares